Abbott Capital Management Inc.

Medarex Subsidiary Celldex, Icagen Planning To Go Public.
BIOWORLD Today; 11/3/2009; 1536 words; ...Celldex Therapeutics Inc., while Icagen Inc. also registered...relating to the management of a clinical trial...purposes and working capital requirements. In...last May as MabVac Inc., and earlier...in concert with Abbott Laboratories...

Reliant IPO Seeking $300M To Advance Heart Portfolio.
BIOWORLD Today; 11/3/2009; 1305 words; ...Reliant Pharmaceuticals Inc. is shooting to raise...Investors LLC, Bay City Capital LLC and Alkermes Inc. - the last of which...Rythmol, purchased from Abbott Laboratories in December...was Antara, for the management of cholesterol levels...

Impax Laboratories Confirms Patent Challenge Relating to TRICOR[R] 48mg and 145mg Tablets.
Business Wire; 10/30/2009; 1269 words; ...Impax Laboratories, Inc. (NASDAQ:IPXL...patents listed by Abbott Laboratories in connection...October 29, 2009, Abbott Laboratories and...Impax Laboratories, Inc. Impax Laboratories...and expectations of management. Such statements...obtain sufficient capital to fund its operations...

NeoGenomics Reports Third Quarter 2009 Results.
PR Newswire; 10/29/2009; 2619 words; ...NeoGenomics, Inc. (OTC Bulletin...to an increase in management personnel. Net...common stock to Abbott Laboratories and...availability on its working capital credit facility...company with a strong management team. I am excited...entered into with Abbott Laboratories in...

Heska Announces Q309 Results.
PR Newswire; 10/27/2009; 1803 words; ...Investor Conference Call Management will conduct a conference...access to products from Abbott Point of Care Inc., which represent...listing on the Nasdaq Capital Market; competition...to raise additional capital, if necessary or advisable...